Literature DB >> 22441965

Increased levels of matrix metalloproteinase-3 in the sera and synovial fluids of patients with pustulotic arthro-osteitis associated with palmoplantar pustulosis: report of 2 cases.

Toshiyuki Yamamoto.   

Abstract

Pustulotic arthro-osteitis (PAO) is occasionally seen in patients with palmoplantar pustulosis (PPP); however, its pathogenesis is still obscure. Herein, two patients with PAO associated with PPP were described. Both patients developed hydrarthrosis on the knees, along with sternocostoclavicular pain. Detail examination revealed odontogenic infection in both cases. Matrix metalloproteinase-3 (MMP-3) is a useful marker reflecting the activity of rheumatoid arthritis. In this study, MMP-3 levels in the sera as well as joint fluids were examined. Serum MMP-3 levels were increased in both cases (274 ng/ml in Case 1 and 242 ng/ml in Case 2, normal; 17.3-59.7). Also, MMP-3 concentration in the joint fluids was markedly elevated (Case 1 > 80,000 ng/ml and 48,000 ng/ml in Case 2). Our studies suggest that MMP-3 may play a role in the pathogenesis of joint involvement of PPP.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22441965     DOI: 10.1007/s00296-012-2405-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  11 in total

1.  Increased IL-23 expression in palmoplantar psoriasis and hyperkeratotic hand dermatitis.

Authors:  Joseph V Lillis; Chang-Sheng Guo; Jennifer J Lee; Andrew Blauvelt
Journal:  Arch Dermatol       Date:  2010-08

2.  Understanding the IL-23-IL-17 immune pathway.

Authors:  Brent S McKenzie; Robert A Kastelein; Daniel J Cua
Journal:  Trends Immunol       Date:  2005-11-14       Impact factor: 16.687

3.  Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy.

Authors:  F M Brennan; K A Browne; P A Green; J M Jaspar; R N Maini; M Feldmann
Journal:  Br J Rheumatol       Date:  1997-06

4.  Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.

Authors:  Yan Zheng; Dimitry M Danilenko; Patricia Valdez; Ian Kasman; Jeffrey Eastham-Anderson; Jianfeng Wu; Wenjun Ouyang
Journal:  Nature       Date:  2006-12-24       Impact factor: 49.962

5.  Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis.

Authors:  A I Catrina; J Lampa; S Ernestam; E af Klint; J Bratt; L Klareskog; A-K Ulfgren
Journal:  Rheumatology (Oxford)       Date:  2002-05       Impact factor: 7.580

6.  IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis.

Authors:  Kerstin Wolk; Ellen Witte; Elizabeth Wallace; Wolf-Dietrich Döcke; Stefanie Kunz; Khusru Asadullah; Hans-Dieter Volk; Wolfram Sterry; Robert Sabat
Journal:  Eur J Immunol       Date:  2006-05       Impact factor: 5.532

7.  Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways.

Authors:  M Laan; Z H Cui; H Hoshino; J Lötvall; M Sjöstrand; D C Gruenert; B E Skoogh; A Lindén
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

8.  Toll-like receptors and rheumatoid arthritis.

Authors:  Fabia Brentano; Diego Kyburz; Steffen Gay
Journal:  Methods Mol Biol       Date:  2009

9.  Differential Toll-like receptor-dependent collagenase expression in chondrocytes.

Authors:  Q Zhang; W Hui; G J Litherland; M J Barter; R Davidson; C Darrah; S T Donell; I M Clark; T E Cawston; J H Robinson; A D Rowan; D A Young
Journal:  Ann Rheum Dis       Date:  2008-02-07       Impact factor: 19.103

Review 10.  Immunopathogenesis of psoriasis.

Authors:  Robert Sabat; Sandra Philipp; Conny Höflich; Stefanie Kreutzer; Elizabeth Wallace; Khusru Asadullah; Hans-Dieter Volk; Wolfram Sterry; Kerstin Wolk
Journal:  Exp Dermatol       Date:  2007-10       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.